Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/02 → 10/31/04 |
Funding
- Bristol Myers Squibb Company: $10,328.00
VEST-QD: A Phase IV, Open-Label, Randomized, Multicenter Study Switching HIV-1 Infected Subjects w/a Viral Load <50 Copies/mL on a First PI-Based Regimen to an Efavirenz Substitution Regimen
- Dehovitz, Jack (PI)
- Warren, David (PI)
Project: Research